Labeler
Azurity Pharmaceuticals, Inc. NDC Codes
Azurity Pharmaceuticals, Inc. lists 57 finished drug products in the FDA NDC Directory under NDC labeler codes 24338, 52652, 60631, 65628.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Zenzedi, Arynta, Firvanq, Gleostine, Widaplik, SUPREP Bowel Prep, FeraBright, Danziten, Azmiro, Nymalize, Evekeo, Edarbi, Ivermectin, GoLYTELY, Suflave
- Active ingredients
- Dextroamphetamine sulfate, Lisdexamfetamine dimesylate, Sodium sulfate, Lomustine, Telmisartan, Amlodipine besylate, Indapamide, Potassium chloride, Potassium sulfate, Magnesium sulfate, Unspecified form, Ferumoxytol, Nilotinib
- NDC labeler codes
- 24338, 52652, 60631, 65628
- Strengths
- Lisdexamfetamine dimesylate 10 mg/mL; Ferumoxytol 30 mg/mL; Testosterone cypionate 200 mg/mL; Ivermectin 5 mg/g; Polyethylene glycol 3350 236 g/4L; Sodium sulfate anhydrous 22.74 g/4L; Sodium bicarbonate 6.74 g/4L; Sodium chloride 5.86 g/4L; Potassium chloride 2.97 g/4L; Sodium sulfate 17.5 g/mL; Potassium sulfate 3.13 g/mL; Magnesium sulfate, Unspecified form 1.6 g/mL; Sodium sulfate 13.13 g/133.1mL; Potassium sulfate 2.35 g/133.1mL; Magnesium sulfate, Unspecified form 1.2 g/133.1mL; Sodium sulfate 17.75 g/1; Magnesium sulfate anhydrous 2.7 g/1; Potassium chloride 2.25 g/1; Lomustine 10 mg/1; Lomustine 40 mg/1
- Dosage forms
- Tablet, Solution, Kit, Injection, Suspension, Capsule, Gelatin coated, Solution, Concentrate, Injection, Solution, Lotion, Powder, For solution, Wafer, Tablet, Film coated
- Routes
- Oral, Intravenous, Intramuscular, Topical, Intracavitary
- Drug classes (FDA established)
- Central Nervous System Stimulant, Osmotic Laxative, Dihydropyridine Calcium Channel Blocker, Alkylating Drug, Angiotensin 2 Receptor Blocker, Potassium Salt, Calcium Channel Blocker, Calculi Dissolution Agent, Thiazide-like Diuretic, Parenteral Iron Replacement, Kinase Inhibitor, Androgen, Angiotensin Converting Enzyme Inhibitor, Antiparasitic, Pediculicide, Central alpha-2 Adrenergic Agonist, Nonsteroidal Anti-inflammatory Drug, Dipeptidyl Peptidase 4 Inhibitor, Antimetabolite Immunosuppressant, Anti-epileptic Agent, gamma-Aminobutyric Acid-ergic Agonist, Folate Analog Metabolic Inhibitor, Antiarrhythmic, Arteriolar Vasodilator, Nitrate Vasodilator
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 68
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Ivermectin | Ivermectin 5 mg/g | LotionTopical | 24338-119 | 24338-0119-45 | — |
| GoLYTELYpolyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride | Polyethylene glycol 3350 236 g/4L + 4 more ingredients | Powder, For solutionOral | 24338-236 | 24338-0236-01 | — |
| Suflavepolyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution | — | Kit | 24338-550 | 24338-0550-01 | — |
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 17.5 g/mL + 2 more ingredients | Solution, ConcentrateOral | 24338-175 | 24338-0175-01 | — |
| SUPREP Bowel Prepsodium sulfate, potassium sulfate, magnesium sulfate | Sodium sulfate 13.13 g/133.1mL + 2 more ingredients | Solution, ConcentrateOral | 24338-177 | 24338-0177-01 | — |
| Sutabsodium sulfate, magnesium sulfate, and potassium chloride | Sodium sulfate 17.75 g/1 + 2 more ingredients | TabletOral | 24338-201 | 24338-0201-01 | — |
| Aryntalisdexamfetamine dimesylate oral | Lisdexamfetamine dimesylate 10 mg/mL | SolutionOral | 24338-019 | 24338-0019-01 | — |
| Aryntalisdexamfetamine dimesylate oral | Lisdexamfetamine dimesylate 10 mg/mL | SolutionOral | 24338-103 | 24338-0103-01 | — |
| Aryntalisdexamfetamine dimesylate oral | Lisdexamfetamine dimesylate 10 mg/mL | SolutionOral | 24338-109 | 24338-0109-01 | — |
| Aryntalisdexamfetamine dimesylate oral | Lisdexamfetamine dimesylate 10 mg/mL | SolutionOral | 24338-160 | 24338-0160-01 | — |
| Aryntalisdexamfetamine dimesylate oral | Lisdexamfetamine dimesylate 10 mg/mL | SolutionOral | 24338-162 | 24338-0162-01 | — |
| Gleostinelomustine | Lomustine 10 mg/1 | Capsule, Gelatin coatedOral | 24338-340 | 24338-0340-05 | — |
| Gleostinelomustine | Lomustine 40 mg/1 | Capsule, Gelatin coatedOral | 24338-341 | 24338-0341-05 | — |
| Gleostinelomustine | Lomustine 100 mg/1 | Capsule, Gelatin coatedOral | 24338-342 | 24338-0342-05 | — |
| Javadinclonidine hydrochloride oral | Clonidine hydrochloride 20 ug/mL | SolutionOral | 24338-115 | 24338-0115-01 | — |
| Widapliktelmisartan, amlodipine and indapamide | Telmisartan 10 mg/1 + 2 more ingredients | TabletOral | 24338-001 | 24338-0001-30 | — |
| Widapliktelmisartan, amlodipine and indapamide | Telmisartan 20 mg/1 + 2 more ingredients | TabletOral | 24338-002 | 24338-0002-30 | — |
| Widapliktelmisartan, amlodipine and indapamide | Telmisartan 40 mg/1 + 2 more ingredients | TabletOral | 24338-003 | 24338-0003-30 | — |
| FeraBrightferumoxytol | Ferumoxytol 30 mg/mL | InjectionIntravenous | 24338-310 | 24338-0310-10 | — |
| FeraBrightferumoxytol | Ferumoxytol 30 mg/mL | InjectionIntravenous | 24338-510 | 24338-0510-17 | — |
| Xifyrmmeloxicam | Meloxicam 30 mg/mL | InjectionIntravenous | 24338-153 | 24338-0153-02 | — |
| Brynovinsitagliptin hydrochloride oral | Sitagliptin 25 mg/mL | SolutionOral | 24338-017 | 24338-0017-01 | — |
| Vivimustabendamustine hydrochloride | Bendamustine hydrochloride 25 mg/mL | InjectionIntravenous | 24338-270 | 24338-0270-01 | — |
| Danzitennilotinib | Nilotinib 71 mg/1 | TabletOral | 24338-154 | 24338-0154-01 | — |
| Danzitennilotinib | Nilotinib 95 mg/1 | TabletOral | 24338-155 | 24338-0155-01 | — |
| Azmirotestosterone cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 24338-055 | 24338-0055-01 | — |
| Azmirotestosterone cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 24338-056 | 24338-0056-01 | — |
| Myhibbinmycophenolate mofetil | Mycophenolate mofetil 200 mg/mL | SuspensionOral | 24338-018 | 24338-0018-01 | — |
| Konvomepomeprazole and sodium bicarbonate | — | Kit | 65628-272 | 65628-0272-0365628-0272-0565628-0272-10 | — |
| Zonisadezonisamide | Zonisamide 100 mg/5mL | SuspensionOral | 52652-8001 | 52652-8001-01 | — |
| Fleqsuvybaclofen | Baclofen 5 mg/mL | SuspensionOral | 52652-6001 | 52652-6001-0152652-6001-02 | — |
| Eprontiatopiramate | Topiramate 25 mg/mL | SolutionOral | 52652-9001 | 52652-9001-0152652-9001-0252652-9001-03 | — |
| Nymalizenimodipine | Nimodipine 30 mg/5mL | SolutionOral | 24338-230 | 24338-0230-1224338-0230-30 | — |
| Nymalizenimodipine | Nimodipine 60 mg/10mL | SolutionOral | 24338-260 | 24338-0260-0824338-0260-12 | — |
| Katerziaamlodipine | Amlodipine benzoate 1 mg/mL | SuspensionOral | 52652-5001 | 52652-5001-01 | — |
| Firvanqvancomycin hydrochloride | — | Kit | 65628-204 | 65628-0204-05 | — |
| Firvanqvancomycin hydrochloride | — | Kit | 65628-205 | 65628-0205-10 | — |
| Firvanqvancomycin hydrochloride | — | Kit | 65628-206 | 65628-0206-05 | — |
| Firvanqvancomycin hydrochloride | — | Kit | 65628-208 | 65628-0208-10 | — |
| Triptodurtriptorelin | — | Kit | 24338-150 | 24338-0150-20 | — |
| Xatmepmethotrexate | Methotrexate 2.5 mg/mL | SolutionOral | 52652-2001 | 52652-2001-0152652-2001-06 | — |
| Epanedenalapril maleate | Enalapril maleate 1 mg/mL | SolutionOral | 52652-4001 | 52652-4001-01 | — |
| Qbrelislisinopril | Lisinopril 1 mg/mL | SolutionOral | 52652-3001 | 52652-3001-01 | — |
| Evekeoamphetamine sulfate | Amphetamine sulfate 5 mg/1 | TabletOral | 24338-022 | 24338-0022-03 | — |
| Evekeoamphetamine sulfate | Amphetamine sulfate 10 mg/1 | TabletOral | 24338-026 | 24338-0026-03 | — |
| Sotylizesotalol hydrochloride | Sotalol hydrochloride 5 mg/mL | SolutionOral | 24338-530 | 24338-0530-2524338-0530-48 | — |
| Zenzedidextroamphetamine sulfate | Dextroamphetamine sulfate 15 mg/1 | TabletOral | 24338-854 | 24338-0854-03 | — |
| Zenzedidextroamphetamine sulfate | Dextroamphetamine sulfate 20 mg/1 | TabletOral | 24338-855 | 24338-0855-03 | — |
| Zenzedidextroamphetamine sulfate | Dextroamphetamine sulfate 30 mg/1 | TabletOral | 24338-856 | 24338-0856-03 | — |
| Zenzedidextroamphetamine sulfate | Dextroamphetamine sulfate 2.5 mg/1 | TabletOral | 24338-850 | 24338-0850-03 | — |
Azurity Pharmaceuticals, Inc.: common questions
- What is Azurity Pharmaceuticals, Inc.'s NDC labeler code?
- 24338, 52652, 60631, 65628. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Azurity Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.